44/100BExelon stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Exelon is 46.40, 1.7% above the current price of 45.61. Their targets range from 41.00 to 50.00.
Of the 15 firms that rated Exelon in the past 12 months, 4 rate it buy or strong buy, 11 hold and 0 sell or strong sell (each firm at its latest rating): a Hold consensus.
Analysts' 1-year price targets range from 41.00 to 50.00, with an average of 46.40.
| Buy | 4 | |
| Hold | 11 | |
| Sell | 0 |
12-month price target
| Highest target | 50.00 |
| Average target | 46.40 |
| Lowest target | 41.00 |
| Current price | 45.61 |
Exelon price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Exelon price target and rating?
How analysts rate Exelon, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
4 of 15 firms rate it buy now, against 5 of 12 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Exelon analyst upgrades, downgrades and price targets
The latest rating change came on 13 October 2026, when Keybanc upgraded Exelon from Underweight to Sector Weight. The most recent new target came from Barclays on 19 October 2026: 44.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 19 Oct 2026 | Barclays | Reiterated · Equal Weight | 50.00 → 44.00 | -12.0% | 43.50 |
| 13 Oct 2026 | Keybanc | Upgraded · Underweight → Sector Weight | — | — | — |
| 22 Sept 2026 | Argus Research Marie Ferguson | Reiterated · Buy | 49.00 | — | 41.98 |
| 18 Sept 2026 | Morgan Stanley | Reiterated · Equal Weight | 55.00 → 50.00 | -9.1% | 42.10 |
| 13 Aug 2026 | Truist Financial | Reiterated · Hold | 49.00 → 48.00 | -2.0% | 45.51 |
| 29 May 2026 | Truist Financial Richard Sunderland | Reiterated · Hold | 50.00 → 49.00 | -2.0% | 45.60 |
| 13 May 2026 | KeyBanc | Reiterated · Underweight | 43.00 → 41.00 | -4.7% | 44.98 |
| 21 Apr 2026 | Morgan Stanley David Arcaro | Reiterated · Equal Weight | 51.00 → 55.00 | +7.8% | 46.41 |
| 21 Apr 2026 | KeyBanc | Reiterated · Underweight | 39.00 → 43.00 | +10.3% | 46.40 |
| 21 Apr 2026 | Wells Fargo | — | 51.00 → 50.00 | -2.0% | 46.40 |
| 20 Apr 2026 | Truist Financial Richard Sunderland | — | 50.00 | — | 46.40 |
| 20 Apr 2026 | RBC Capital Stephen D'Ambrisi | Reiterated · Sector Perform | 51.00 → 48.00 | -5.9% | 47.20 |
| 20 Apr 2026 | Jefferies | Downgraded · Buy → Hold | 57.00 → 50.00 | -12.3% | 47.02 |
| 17 Apr 2026 | Mizuho Securities Anthony Crowdell | — | 51.00 → 48.00 | -5.9% | 47.59 |
| 17 Apr 2026 | BMO Capital | Downgraded · Outperform → Market Perform | 51.00 → 49.00 | -3.9% | 47.59 |
| 17 Apr 2026 | Barclays | Downgraded · Overweight → Equal Weight | — | — | — |
| 20 Feb 2026 | UBS | Reiterated · Neutral | 48.00 → 51.00 | +6.3% | 47.35 |
| 13 Feb 2026 | Scotiabank | Reiterated · Sector Perform | 47.00 | — | 48.69 |
| 13 Feb 2026 | Mizuho Securities | Reiterated · Outperform | 51.00 | — | 47.55 |
| 13 Feb 2026 | BMO Capital | Reiterated · Outperform | 51.00 | — | 47.88 |
| 22 Jan 2026 | Barclays Nicholas Campanella | Reiterated · Overweight | 52.00 → 50.00 | -3.8% | 45.00 |
| 21 Jan 2026 | Morgan Stanley David Arcaro | — | 52.00 → 51.00 | -1.9% | 44.70 |
| 20 Jan 2026 | Wells Fargo Shahriar Pourreza | Reiterated · Overweight | 51.00 | — | 44.73 |
| 7 Jan 2026 | RBC Capital Stephen D'Ambrisi | — | 51.00 | — | 43.84 |
| 17 Dec 2025 | UBS | Reiterated · Neutral | 50.00 → 48.00 | -4.0% | 43.76 |
| 12 Dec 2025 | KeyBanc | — | 42.00 → 39.00 | -7.1% | 43.10 |
| 20 Nov 2025 | Morgan Stanley David Arcaro | — | 53.00 → 52.00 | -1.9% | 45.48 |
Exelon EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Exelon's EPS to grow 5.9% a year until 2028. Over the last 5 years it grew 6.4% a year, and over the last 3 years 9.6%.
Analysts expect Exelon's revenue to grow 3.7% a year until 2028. Over the last 5 years it fell 6.0% a year, and over the last 3 years it grew 8.3%.
Revenue
EPS
Does Exelon beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 6.8% off the result, either way, and their revenue estimate 10.0%, over the last 12 quarters.
- EPS beats
- 81 / 136
- Revenue beats
- 84 / 119
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +6.1%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 30 Oct 2026 | 0.79 | 0.87 | +10.4% | 6.76B | 7.32B | +8.3% |
| Q2 FY2026 | 30 Jul 2026 | 0.44 | 0.43 | -1.3% | 5.44B | 5.97B | +9.6% |
| Q1 FY2026 | 6 May 2026 | 0.88 | 0.91 | +2.9% | 6.93B | 7.24B | +4.6% |
| Q4 FY2025 | 12 Feb 2026 | 0.55 | 0.59 | +7.9% | 5.39B | 5.41B | +0.4% |
| Q3 FY2025 | 4 Nov 2025 | 0.78 | 0.86 | +10.5% | 6.43B | 6.71B | +4.3% |
| Q2 FY2025 | 31 Jul 2025 | 0.37 | 0.39 | +6.2% | 5.38B | 5.43B | +0.9% |
| Q1 FY2025 | 1 May 2025 | 0.88 | 0.92 | +4.9% | 6.52B | 6.71B | +3.0% |
| Q4 FY2024 | 12 Feb 2025 | 0.59 | 0.64 | +8.1% | 4.51B | 5.47B | +21.2% |
| Q3 FY2024 | 30 Oct 2024 | 0.67 | 0.71 | +6.0% | 5.85B | 6.15B | +5.1% |
| Q2 FY2024 | 1 Aug 2024 | 0.40 | 0.47 | +17.5% | 4.63B | 5.36B | +15.8% |
| Q1 FY2024 | 2 May 2024 | 0.70 | 0.68 | -2.9% | 5.57B | 6.04B | +8.5% |
| Q4 FY2023 | 21 Feb 2024 | 0.58 | 0.60 | +3.4% | 3.87B | 5.37B | +38.8% |
Exelon stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Exelon's earnings keep growing at the 5.6% a year analysts expect to FY2028, it would earn about 3.63 a share in FY2030. At the P/E it has traded at over the last five years (15.3 to 23.7) that is 55.68 to 85.91 a share, or 65.13 at its average P/E of 17.9. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 2.87 | 43.98 | 51.45 | 67.87 |
| FY2027 | 3.03 | 46.49 | 54.38 | 71.73 |
| FY2028 | 3.25 | 49.90 | 58.38 | 77.00 |
| FY2029 (extrapolated) | 3.44 | 52.71 | 61.66 | 81.34 |
| FY2030 (extrapolated) | 3.63 | 55.68 | 65.13 | 85.91 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 5.6% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (15.3, 17.9, 23.7).
Is Exelon stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Exelon's P/E of 17.7 is above the middle of its 5-year range (14.7 to 24.1, median 16.8). Analysts do not expect faster growth than in recent years, so it is expensive compared with its own history. Buyers pay about the usual price for each point of growth: a PEG of 3.0 on expected growth against 2.6 on its median P/E and past five years' growth. At its usual P/E (16.8 × EPS of 2.57), Exelon's fair value is 43.08; the price, 45.61, is 5.9% above it. Its forward P/E, on the consensus for FY2026, is 15.9.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (14.7 and 24.1). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 17.75
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 16.76
- Five-year P/E range
- 14.7 – 24.1
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 15.91
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 3.15
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +1.7%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 64.525 | 127.9762Price 64.53185 | +98.3% | |
| 28.410 | 56.3234Price 28.4196 | +98.2% | |
| 153.725 | 297.58169Price 153.73471 | +93.6% | |
| 243.002 | 464.71205Price 243.00627 | +91.2% | |
| 160.085 | 305.52160Price 160.09396 | +90.8% | |
| 37.565 | 71.4258Price 37.57193 | +90.1% | |
| 160.240 | 300.28225Price 160.24375 | +87.4% |
Furthest below the fair value on each stock's page, updated every day.